FDA Raises Concerns About Probiotic Products Sold for Use in Hospitalized Preterm Infants

Warning Letters Issued to Two Companies for Illegally Selling Probiotic Products to Treat Diseases in Preterm Infants SILVER SPRING, Md., Oct. 26, 2023 /PRNewswire/ — As part of the U.S. Food and Drug Administration’s commitment to protecting public health, the agency is advising the…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.